- Overall and Gender-specific Associations between C-reactive Protein and Stroke Occurrence: A Cross-sectional Study in US
-
Peng Y, Dong B, Wang Z
- KMID: 2359514
- J Stroke.
- 2016 Sep;18(3):355-357.
- doi: 10.5853/jos.2016.00451
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Free Anthraquinones Extract from the Rhubarb on Cell Proliferation and Accumulation of Extracellular Matrix in High Glucose Cultured-Mesangial Cells
-
Wang J, Fang H, Dong B, Wang D, Li Y, Chen X, Chen L, Wei T, Wei Q
- KMID: 2070787
- Korean J Physiol Pharmacol.
- 2015 Nov;19(6):485-489.
- doi: 10.4196/kjpp.2015.19.6.485
Diabetic nephropathy (DN) is the leading cause of end-stage failure of the kidney, but the efficacy of currently available strategies for the prevention of DN remains unsatisfactory. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
-
Liu C, You H, Zeng QL, Wong YJ, Wang B, Grgurevic I, Liu C, Yim HJ, Gou W, Dong B, Ju S, Guo Y, Yu Q, Hirooka M, Enomoto H, Hanafy AS, Cao Z, Dong X, LV J, Kim TH, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Xu C, Dai E, Lan X, Lai C, Liu S, Wang F, Guo Y, Lv J, Zhang L, Wang Y, Xie Q, Shao C, Liu Z, Ravaioli F, Colecchia A, Li J, Teng GJ, Qi X
- KMID: 2563414
- Clin Mol Hepatol.
- 2025 Jan;31(1):105-118.
- doi: 10.3350/cmh.2024.0198
Backgrounds/Aims: Non-invasive models stratifying clinically significant portal hypertension (CSPH) are limited. Herein, we developed a new non-invasive model for predicting CSPH in patients with compensated cirrhosis and investigated whether carvedilol... -
- CITED
-
- Close
- SHARE
-
- Close
- PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort
-
Kang Y, Sun P, Mao X, Dong B, Ruan G, Chen L
- KMID: 2440504
- J Gynecol Oncol.
- 2019 May;30(3):e29.
- doi: 10.3802/jgo.2019.30.e29
OBJECTIVE: To evaluate the polymerase chain reaction (PCR)-reverse-dot-blot (RDB) human papillomavirus (HPV) genotyping test as a feasible assay for the cervical cancer primary screening. METHODS: In a hospital-based cohort, a total... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study
-
Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, Lin F
- KMID: 2413217
- J Gynecol Oncol.
- 2017 Sep;28(5):e50.
- doi: 10.3802/jgo.2017.28.e50
OBJECTIVE: To determine the clinical significance of the polymerase chain reaction (PCR)-reverse dot blot (RDB) human papillomavirus (HPV) genotyping assay in cervical cancer screening. METHODS: A total of 10,442 women attending... -
- CITED
-
- Close
- SHARE
-
- Close
